|
3 Companies |
|
1 Product |
|
1 Product |
|
4 Mechanisms of Action |
|
0 Trials |
|
6 News |
|
- Orencia (abatacept) / BMS
Preclinical, Enrollment change, Trial withdrawal: Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis (clinicaltrials.gov) - May 12, 2016
P4, N=0, Withdrawn, Sponsor: University of California, Los Angeles
N=24 --> 0 | Not yet recruiting --> Withdrawn
- | Orencia (abatacept) / BMS
New P4 trial, Preclinical: Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis (clinicaltrials.gov) - Oct 23, 2012
P4, N=24, Not yet recruiting, Sponsor: University of California, Los Angeles